Nature's Sunshine Products Inc (NATR): EPS (Diluted)
$1.06
Year ended 2025-12-31
-0.2%
5-year compound annual growth
+3.2%
10-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.06 | +165.0% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $0.40 | -48.1% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $0.77 | n/m | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | -$0.02 | n/m | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | $1.42 | +32.7% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $1.07 | +214.7% | 2022-03-08, From 2020-01-01 |
| 2019-12-31 | $0.34 | n/m | 2021-03-10, From 2019-01-01 |
| 2018-12-31 | -$0.04 | n/m | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | -$0.69 | n/m | 2019-03-08, From 2017-01-01 |
| 2016-12-31 | $0.11 | -85.7% | 2019-03-08, From 2016-01-01 |
| 2015-12-31 | $0.77 | +37.5% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $0.56 | -47.7% | 2017-03-14, From 2014-01-01 |
| 2013-12-31 | $1.07 | -32.7% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $1.59 | +42.0% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | $1.12 | n/m | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | -$0.08 | n/m | 2013-03-07, From 2010-01-01 |
| 2009-12-31 | $0.39 | n/a | 2012-03-05, From 2009-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $1.06 | +165.0% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$0.29 | n/m |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$3.78 | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$0.16 | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | -$0.47 | n/m |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $0.52 | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $3.30 | +816.7% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $0.15 | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$0.26 | n/m |
Compare NATR, TVTX, BBIO, ZLAB side by side · Screen every company in Pharmaceutical Preparations ↗